Literature DB >> 28149634

Clinical value of nodal micrometastases in patients with non-small cell lung cancer: time for reconsideration?

Angelo Carretta1.   

Abstract

Entities:  

Year:  2016        PMID： 28149634      PMCID： PMC5227259          DOI： 10.21037/jtd.2016.12.83

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

Review 1.  Prognostic significance of micrometastasis in non-small-cell lung cancer.

Authors:  Michael C Coello; James D Luketich; Virginia R Litle; Tony E Godfrey
Journal:  Clin Lung Cancer       Date:  2004-01       Impact factor: 4.785

2.  Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt.

Authors:  Elisa Meacci; Alfredo Cesario; Giacomo Cusumano; Filippo Lococo; Rolando D'Angelillo; Valentina Dall'armi; Stefano Margaritora; Pierluigi Granone
Journal:  Eur J Cardiothorac Surg       Date:  2011-03-12       Impact factor: 4.191

3.  Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance).

Authors:  Linda W Martin; Jonathan D'Cunha; Xiaofei Wang; Debra Herzan; Lin Gu; Naif Abraham; Todd L Demmy; Frank C Detterbeck; Shawn S Groth; David H Harpole; Mark J Krasna; Kemp Kernstine; Leslie J Kohman; G Alexander Patterson; David J Sugarbaker; Robin T Vollmer; Michael A Maddaus; Robert A Kratzke
Journal:  J Clin Oncol       Date:  2016-02-29       Impact factor: 44.544

4.  Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.

Authors:  Elena Garelli; Stéphane Renaud; Pierre-Emmanuel Falcoz; Noëlle Weingertner; Anne Olland; Nicola Santelmo; Gilbert Massard
Journal:  Eur J Cardiothorac Surg       Date:  2016-02-25       Impact factor: 4.191

5.  The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer.

Authors:  Ad F Verhagen; Johan Bulten; Hebste Shirango; Frederik B J M Thunnissen; Miep A van der Drift; Wouter van der Bruggen; Vivianne C G Tjan-Heijnen; Henry A van Swieten
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

6.  Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.

Authors:  Mario Nosotti; Monica Falleni; Alessandro Palleschi; Caterina Pellegrini; Francesca Alessi; Silvano Bosari; Luigi Santambrogio
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

7.  Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial.

Authors:  Valerie W Rusch; Debra Hawes; Paul A Decker; Sue Ellen Martin; Andrea Abati; Rodney J Landreneau; G Alexander Patterson; Richard I Inculet; David R Jones; Richard A Malthaner; Robbin G Cohen; Karla Ballman; Joe B Putnam; Richard J Cote
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

Review 8.  The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.

Authors:  Hisao Asamura; Kari Chansky; John Crowley; Peter Goldstraw; Valerie W Rusch; Johan F Vansteenkiste; Hirokazu Watanabe; Yi-Long Wu; Marcin Zielinski; David Ball; Ramon Rami-Porta
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

9.  Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction.

Authors:  C T Salerno; S Frizelle; G A Niehans; S B Ho; M Jakkula; R A Kratzke; M A Maddaus
Journal:  Chest       Date:  1998-06       Impact factor: 9.410

10.  Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.

Authors:  Ottavio Rena; Luca Carsana; Silvia Cristina; Esther Papalia; Fabio Massera; Luca Errico; Cristina Bozzola; Caterina Casadio
Journal:  Eur J Cardiothorac Surg       Date:  2007-11-01       Impact factor: 4.191
View more
  3 in total

1.  Examined lymph node count in non-small-cell lung cancer: will it be a decision making approach in treatment of NSCLC?

Authors:  Renwang Liu; Jun Chen; Song Xu
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Malignant thoracic lymph node classification with deep convolutional neural networks on real-time endobronchial ultrasound (EBUS) images.

Authors:  Seung Hyun Yong; Sang Hoon Lee; Sang-Il Oh; Ji-Soo Keum; Kyung Nam Kim; Moo Suk Park; Yoon Soo Chang; Eun Young Kim
Journal:  Transl Lung Cancer Res       Date:  2022-01

3.  The Significance of the Alter miR let-7a and miR-335 Expression Level Regulating the CCR7/CCL19 Axis as Potential Biomarkers of Tumor Progression in NSCLC.

Authors:  Kamila Baran; Jacek Kordiak; Sławomir Jabłoński; Adam Antczak; Ewa Brzeziańska-Lasota
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.